Literature DB >> 11600085

A high performance liquid chromatographic method for the estimation of diethylcarbamazine content in medicated salt samples.

N Mathew1, M Kalyanasundaram.   

Abstract

A simple and reproducible method for the estimation of diethylcarbamazine citrate (DEC) by high performance liquid chromatography (HPLC) in DEC-medicated salt was developed. HPLC analysis was conducted with a mobile phase containing acetonitrile/phosphate buffer (20 mM KH(2)PO(4,) adjusted to pH 3.2 with 10% ortho-phosphoric acid) in the ratio of 1:9 and at a flow rate of 1.5 ml/min. A Phenomenex C8 column (15 cmx4.6 mm) of 5 microm particle size was used for the analysis. Analysis was done at UV 210 nm, 0.02 a.u.f. and 40 degrees C. The coefficient of variation was <10% in the range of 1-25 microg/ml and the minimum detectable level was 0.5 microg/ml. The quality of DEC-medicated salt prepared by two methods was analyzed by using the HPLC method. In spray drying method, 29 and 71% of the samples and in rotating drum method, 9 and 12% of samples were found to contain DEC at 0.15-0.25% and >0.25%, respectively. Thus, this quick and simple HPLC method for the estimation of DEC could play a vital role in checking the quality of the DEC medicated salt used for the control of filariasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600085     DOI: 10.1016/s0001-706x(01)00163-2

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  2 in total

1.  A low-tech analytical method for diethylcarbamazine citrate in medicated salt.

Authors:  Abigail Weaver; Patrick Brown; Shannon Huey; Marco Magallon; E Brennan Bollman; Dominique Mares; Thomas G Streit; Marya Lieberman
Journal:  PLoS Negl Trop Dis       Date:  2011-02-08

2.  A Sensitive RP-HPLC Method for Simultaneous Estimation of Diethylcarbamazine and Levocetirizine in Tablet Formulation.

Authors:  J Mahesh Reddy; M R Jeyaprakash; K Madhuri; S N Meyyanathan; K Elango
Journal:  Indian J Pharm Sci       Date:  2011-05       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.